DSW Blog: Why invest in R&D for HIV, TB and malaria? Because it’s good for global health, and good for Europe
Eoghan Walsh, communications officer at Deutsche Stiftung Weltbevoelkerung (DSW), introduces “a series of policy briefs on the issue of global health research and development, outlining why we need to increase financial and political support (in Europe) for efforts aimed at creating new ways to tackle diseases such as HIV and AIDS, TB, and malaria…” (9/4).